GLPwatch
Reducing CV risk in diabetes: An ADA update.
J Fam Pract · 2017
Last updated 2026-05-28| Journal | J Fam Pract, 2017 |
|---|---|
| Citations | 3 |
| Relative citation ratio | 0.10 |
| NIH percentile | 7 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes, Cardiovascular Risk Reduction |
Abstract
This Q&A highlights changes to the ADA's 2017 Standards of Care to help you fine-tune your approach to patients who have, or are at risk for, atherosclerotic CV disease.
Verbatim abstract via PubMed 28459890 ↗